TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/20/24 16:26 | 6/18/24 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Farrow Jeffrey S | CA | O | See Rema | S.d | -287 | 27.47 | 0 | -10 | -37 | 18 | D | ||||||||||||||
9/6/22 19:00 | 9/1/22 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Farrow Jeffrey S | CA | O | CFO | S.d | -2,138 | 68.00 | 0 | -31 | -91 | 3 | D | ||||||||||||||
7/15/20 17:11 | 7/13/20 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Farrow Jeffrey S | CA | O | CFO | S | -1,141 | 75.00 | 0 | -15 | -83 | 3 | D | ||||||||||||||
6/11/20 16:06 | 6/9/20 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Farrow Jeffrey S | CA | O | CFO | S | -1,019 | 67.00 | 0 | -15 | -45 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |